ADESSO BIOPRODUCTS AS

Operating

Direkte eller indirekte gjennom datterselskaper i selskapets konsern, å selge kjemikalier, annet type brensel og energi utvunnet og produsert av biologiske råvarer, herunder utvikling og salg av tilhørende teknologi i forbindelse med utvinning og produksjon av energi fra slike biologiske råvarer, samt all annen virksomhet tilknyttet dette, herunder å eie aksjer i andre selskaper.

Produsere og selge biodiesel, kjemikalier, annet type brensel og energi utvunnet fra biologiske råvarer, herunder utvikling og salg av tilhørende teknologi i forbindelse med utvinning og produksjon av energi fra slike biologiske råvarer.

Keywords

productionpropellantexplosivespyrotechnic productsfuse capsdetonatorsflaresmatches

Organization

CEO: LL
Lars-Olof Lind1955
Chairman of the board: LL
Lars-Olof Lind1955
Years since formation: 10 years; since Jul 9, 2015
Type: Limited company
VAT registered: Yes
Number of employees: 17

Ownership

Number of shares and share classes: 2,400; 1 share class
Total number of shareholders: 1; person

Financials

Total operating income 2024: 52,541,129; NOK
Annual total result 2024: 2,002,473; NOK
Total equity 2024: 43,607,840; NOK

Last update: Nov 12, 2025

Management

Management / administration

Name	Role	Shares
LL Lars-Olof Lind 1955	Managing Director/CEO	-

Board

Name	Role	Shares
LL Lars-Olof Lind 1955	Chairman	-
RJ Runar Jensen 1968	Board Member	-
PG Philipp Günter Gräber 1982	Alternate Member	-

Others

Name	Role	Shares
Ø ØST-REVISJON AS	Auditor	-
W WICAN REGNSKAP AS	Accountant	-

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
AB Adesso Bioproducts Ab	Ordinary shares	2,400	100 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2024	2023	2022
Total operating income	52,541,129	85,689,779	105,368,430
Annual Total Result	2,002,473	3,758,797	5,205,901
Total assets	59,847,008	66,310,193	80,634,369
Total liabilities	16,239,168	24,704,826	42,787,798
Total equity	43,607,840	41,605,367	37,846,571

P&L

Year	2024	2023	2022
Total operating income	52,541,129	85,689,779	105,368,430
Total operating costs	49,876,145	79,881,410	98,344,709
Operating result	2,664,984	5,808,369	7,023,721
Financial income/costs	48,779	-984,345	-340,943
Profit before tax	2,713,763	4,824,024	6,682,778
Total tax & extraordinary income/cost	711,290	1,065,227	1,476,877
Annual Total Result	2,002,473	3,758,797	5,205,901

Balance overview

Year	2024	2023	2022
Total fixed assets	17,681,232	16,529,717	16,128,495
Total current assets	42,165,776	49,780,476	64,505,874
Total assets	59,847,008	66,310,193	80,634,369
Short term debt	16,239,168	24,002,707	42,011,882
Long term debt	0	702,119	775,916
Total liabilities	16,239,168	24,704,826	42,787,798
Contributed capital	15,100,800	15,100,800	15,100,800
Retained earnings	28,507,040	26,504,567	22,745,771
Total equity	43,607,840	41,605,367	37,846,571
Total equity and liabilities	59,847,008	66,310,193	80,634,369

Classification

21st company classification

BETA

Industrial large enterprise

ADESSO BIOPRODUCTS AS815 643 062